Photodynamic therapy in veterinary medicine: Current status and implications for applications in human disease

Journal of Clinical Laser Medicine and Surgery

Volumn 14, Issue 5, 1996, Pages 305-310

  Lucroy, Michael D ^a   Magne, Michael L ^a   Peavy, George M ^b   Madewell, Bruce R ^a   Edwards, Benjamin F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPOSITION EFFECTS; DISEASES; LASER APPLICATIONS; LASER TISSUE INTERACTION; PHOTOCHEMICAL REACTIONS; PHYSIOLOGICAL MODELS;

VETERINARY MEDICINE;

PHOTODYNAMIC THERAPY;

AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; CHLOROALUMINUM PHTHALOCYANINE; CORTICOSTEROID; HEMATOPORPHYRIN DERIVATIVE; PHEOPHORBIDE; PHOTOFRIN; PHOTOFRIN II; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PORPHYRIN DERIVATIVE; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; TETRASULFOPHTHALOCYANINE ALUMINUM;

ANIMAL MODEL; ARTICLE; BLADDER CANCER; DRUG BLOOD LEVEL; DRUG METABOLISM; EDEMA; FIBROSARCOMA; INTRAVENOUS DRUG ADMINISTRATION; MASTOCYTOMA; MELANOMA; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOSARCOMA; PHOTODYNAMIC THERAPY; PROSTATE CARCINOMA; SEBACEOUS GLAND TUMOR; SQUAMOUS CELL CARCINOMA; TOPICAL DRUG ADMINISTRATION; VETERINARY MEDICINE; VIRUS INFECTION;

EID: 0030273607     PISSN: 10445471     EISSN: None     Source Type: Journal    
DOI: 10.1089/clm.1996.14.305     Document Type: Article

References (43)

1. Daniell, M.D., and Hill, J.S. (1991). A history of photodynamic therapy. Aust. N. Z. J. Surg. 61, 340-348.
2. Jesionek, A., and Tappeiner, V.H. (1903). Zur Behandlung der Hautcarcinomit mit fluorescierenden stoffen. Muench. Med. Wochneshr. 47, 2042.
3. Dougherty, T.J., Thoma, R.E., Boyle, D.G., and Weishaupt, K.R. (1981). Interstitial photoradiation therapy for primary solid tumors in pet cats and dogs. Cancer Res. 41, 401-404.
4. Cheli, R., Addis, F., Mortellaro, C.M., Fonda, D., Andreoni, A., and Cubeddu, R. (1984). Hematoporphyrin derivative photochemotherapy of spontaneous animal tumors: Clinical results with optimized drug dose. Cancer Lett. 23, 61-66.
5. Cheli, R., Addis, F., Mortellaro, C.M., Fonda, D., and Cubeddu, R. (1987). Photodynamic therapy of spontaneous animal tumors using the active component of hematoporphyrin derivative (HPE) as a photosensitizing drug: Clinical result. Cancer Lett. 38, 101-105.
6. Thoma, R.E. (1989). Photodynamic threapy, in: Clinical Veterinary Oncology. S.J. Withrow and E.G. MacEwen (eds.). Philadelphia: JB Lippincott Co., pp. 124-127.
7. Beck, E.R., and Dunstan, R.W. (1992). Response and toxicity of photodynamic therapy for canine bladder carcinoma. Proc. Int. Conf. Photodynamic Therapy Med. Laser Appl., Milan, Italy.
8. Roberts, W.G., Klein, M.K., Loomis, M., Weldy, S., and Berns, M.W. (1991). Photodynamic therapy of spontaneous cancers in felines canines and snakes with chloro-aluminum sulfonated phthalocyanine. J. Natl. Cancer Inst. 83, 18-23.
9. Peavy, G.M., Klein, M.K., Newman, H.C., Roberts, W.G., and Berns, M.W. (1991). The use of chloro-aluminum sulfonated phthalocyanine as a photosensitizer in the treatment of malignant tumors in dogs and cats. Soc. Photo-Optic Instrum. Eng. 1424, 171-178.
10. Peaston, A.E., Leach, M.W., and Higgins, R.J. (1993). Photodynamic therapy for nasal and aural squamous cell carcinoma in cats. J. Am. Vet. Med. Assoc. 202(8), 1261-1265.
11. Leach, M.W., and Peaston, A.E. (1994). Adverse drug reaction attributable to aluminum phthalocyanine tetrasulphonate administration in domestic cats. Vet. Pathol. 31, 283-287.
12. Pandey, R.K., Shiau, F.Y., Sumlin, A.B., Dougherty, T.J., and Smith, K.M. (1992). Structure/activity relationships among photosensitizers related to pheophorbide and bacteriopheophorbides. Bioorg. Med. Chem. Lett. 2, 491-496.
13. Magne, M.L., Rodriguez, C.O., Autry, S.A., Edwards, B.F., Théon, A.P., and Madewell, B.R. (1996). Photodynamic therapy of facial squamous cell carcinoma in cats using a new photosensitizer. Lasers Surg. Med. (in press).
14. Ferrario, A., and Gomer, C.J. (1989). Lethality in mice following localized photodynamic therapy. Soc. Photo-optic. Instrum. Eng. 1065, 50-54.
15. Ferrario, A., and Gomer, C.J. (1990). Systemic toxicity in mice induced by localized porphyrin photodynamic therapy. Cancer Res. 50, 539-543.
16. Théon, A.P., Madewell, B.R., Shearn, V.I., and Moulton, J.E. (1995). Prognostic factors associated with radiotherapy of squamous cell carcinoma of the nasal plane in cats. J. Am. Vet. Med. Assoc. 206(7), 991-996.
17. Payne, J.T., McCaw, D.L., Rogers, K., and Tompson, R.V. (1995). Treatment of naturally occurring hemangiopericytoma and oral squamous cell carcinoma in dogs using surgery and photodynamic therapy with HPPH as a photosensitizer. Soc. Photo-optic. Instrum. Eng. 2395, 622-626.
18. Peavy, G.M., Krasieva, T.B., Tromberg, B.J., Eusantos, E.D., and Berns, M.W. (1991). Variation in the distribution of a phthalocyanine photosensitizer in naturally occurring tumors of animals. J. Photochem. Photobiol. 27, 271-277.
19. Payne, J.T., McCaw, D.L., Casteel, S.W., Frazier, D., Rogers, K., and Tompson, R.V. (1996). Pharmacokinetics of pyropheophorbide-a-hexyl ether in the dog. Lasers Surg. Med. 18, 406-409.
20. North, J., Freeman, S., Overbaugh, J., Levy, J., and Lansman, R. (1992). Photodynamic inactivation of retrovirus by benzoporphyrin derivative: A feline leukemia virus model. Transfusion 32, 121-128.
21. MacEwen, E.G. (1990). Spontaneous tumors in dogs and cats: Models for the study of cancer biology and treatment. Cancer Metast. Rev. 9, 125-136.
22. Hewitt, H.B. (1978). The choice of animal tumors for experimental studies of cancer therapy. Adv. Cancer Res. 27, 149-200.
23. Ogilvie, G.K., and Moore, A.S. (eds.). (1995). Managing the Veterinary Cancer Patient. Trenton: Veterinary Learning Systems, Co.
24. Theilen, G., and Madewell, B.R. (eds.). (1987). Veterinary Cancer Medicine, 2nd ed. Philadelphia: Lea & Febiger.
25. Withrow, S., and MacEwen, E.G. (eds.). (1996). Small Animal Clinical Oncology, 2nd ed. Philadelphia: W.B. Saunders Co.
26. Peavy, G.M., Krasieva, T.B., Tromberg, B.J., and Berns, M.W. (1994). Treatment considerations for photodynamic therapy in the cat. Soc. Photo-optic. Instrum. Eng. 2128, 568-575.
27. Fivenson, D.P., Saed, G.M., Beck, E.R., Dunstan, R.W., and Moore, P.F. (1994). T-cell receptor gene rearrangement in canine mycosis fungoides: Further support for a canine model of cutaneous T-cell lymphoma. J. Invest. Derm. 102, 227-230.
28. Moore, P.F., Olivry, T., and Naydan, D. (1994). Canine cutaneous epitheliotrophic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T-cells Am. J. Pathol. 144, 421-129.
29. Gardner, D.G. (1995). Canine acanthomatous epulis. The only common spontaneous ameloblastoma in animals. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodon. 79, 612-615.
30. Hopper, C. (1996). The role of photodynamic therapy in the management of oral cancer and precancer. Oral Oncol. Eur. J. Cancer 32(B), 71-72.
31. Grossweiner, L.I. (1995). Photodynamic therapy. J. Laser Appl. 7, 51-57.
32. Nseyo, U.O., Whalen, R.K., and Lundhal, S.L. (1993). Canine bladder responses to red and green light whole bladder photodynamic therapy. Urology 41(4), 392-396.
33. Selman, S.H., and Keck, R.W. (1994). The effect of transurethral light on the canine prostate after sensitization with the photosensitizer tin (II) etiopurpurin dichloride. A pilot study. J. Urol. 152, 2129-2132.
34. Fisher, A.M., Murphree, A.L., and Gomer, C.J. (1995). Clinical and preclinical photodynamic therapy. Lasers Surg. Med. 17(1), 2-31.
35. Boehncke, W.H., Sterry, W., and Kaufmann, R. (1994). Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 343, 801.
36. Divans, D.X.G., Kennedy, J.C., and Pettier, R.H. (1990). Phototoxic damage to sebaceous glands and hair follicles after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am. J. Pathol. 136, 891-897.
37. Malik, Z., Kostenich, G., Roitman, L., Ehrenberg, B., and Orenstein, A. (1995). Topical application of 5-aminolevulinic acid, DMSO, and EDTA: Protoporphyrin IX accumulation in skin and tumours of mice. J. Photochem. Photobiol. B 28, 213-218.
38. Trauner, K.B., Gandour-Edwards, R., Shortkroff, S., et al. (1995). Photodynamic synovectomy with benzoporphyrin derivative in a rabbit model of rheumatoid arthritis. Am. Soc. Lasers Med. Surg. (Abstract 204, 44).
39. Trauner, K., Candour-Edwards, R., Nishioka, N.S., Flotte, T., and Hasan, T. (1995). Photodynamic therapy synovectomy with photofrin (PF) in an antigen induced arthritis model for rheumatoid arthritis. Am. Soc. Lasers Med. Surg. (Abstract 150, 32).
40. Pedersen, N.C., Weisner, K., Castles, J.J., Ling, C.V., and Weiser, G. (1976). Noninfectious canine arthritis: The inflammatory, nonerosive arthritides. J. Am. Vet. Med. Assoc. 169(3), 304-310.
41. Pedersen, N.C., Pool, R.R., and O'Brien, T. (1980). Feline chronic progressive polyarthritis. Am. J. Vet. Res. 41(4), 522-535.
42. Pedersen, N.C., Pool, R.R., Castles, J.J., and Weisner, K. (1976). Noninfectious canine arthritis: Rheumatoid arthritis. J. Am. Vet. Med. Assoc. 169(3), 295-303.
43. Minnock, A., Vernon, D.I., Schofield, J., Griffiths, J., Parish, J.H., and Brown, S.T. (1996). Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both gram-negative and gram-positive bacteria. J. Photochem. Photobiol. B 32(3), 159-164.